Biosynthesis of plant-derived ginsenoside Rh2 in yeast via repurposing a key promiscuous microbial enzyme
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 25,486 · cited 1×
“The PPD substrate was docked into the acceptor binding pocket using the automated docking program Autodock 4.2.6 (Morris et al., 2009) (Fig.”
MethodInfluentialGlycosyltransferases: Structures, Functions, and Mechanisms
Lairson, L. L., Henrissat, B., Davies, G. J., & Withers, S. G. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.061005.092322 · Cited by 2,079 · cited 2×
“conformational changes upon substrate binding (Lairson et al., 2008; Qasba et al., 2005), precisely defining the residues related to acceptor binding and catalytic activity is difficult when the crystal structure of the enzyme-acceptor complex is unknown.”
BackgroundEngineering a mevalonate pathway in Escherichia coli for production of terpenoids
Martin, V. J. J., Pitera, D. J., Withers, S. T., Newman, J. D., & Keasling, J. D. (2003) · Nature Biotechnology · doi:10.1038/nbt833 · Cited by 1,725 · cited 2×
“With the development of synthetic biology, substantial progress has been made in the low-cost production of plant natural products in microbes, including artemisinin (Martin et al., 2003), Taxol (Ajikumar et al.”
BackgroundIsoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli
Ajikumar, P. K., Xiao, W.-H., Tyo, K. E. J., Wang, Y., Simeon, F., Leonard, E., Mucha, O., Phon, T. H., Pfeifer, B., & Stephanopoulos, G. (2010) · Science · doi:10.1126/science.1191652 · Cited by 1,677 · cited 2×
“, 2003), Taxol (Ajikumar et al., 2010), strictosidine (Brown et al.”
BackgroundComplete biosynthesis of opioids in yeast
Galanie, S., Thodey, K., Trenchard, I. J., Filsinger Interrante, M., & Smolke, C. D. (2015) · Science · doi:10.1126/science.aac9373 · Cited by 985 · cited 2×
“With the development of synthetic biology, substantial progress has been made in the low-cost production of plant natural products in microbes, including artemisinin (Martin et al., 2003), Taxol (Ajikumar et al., 2010), strictosidine (Brown et al., 2015), and opioids (Galanie et al., 2015).”
BackgroundIterative saturation mutagenesis (ISM) for rapid directed evolution of functional enzymes
Reetz, M. T., & Carballeira, J. D. (2007) · Nature Protocols · doi:10.1038/nprot.2007.72 · Cited by 860 · cited 1×
“Iterative saturation mutagenesis (ISM) (Reetz and Carballeira, 2007) was performed on each of the nine residues via an arbitrarily selected pathway (A-B-C-D).”
MethodDe novo production of the plant-derived alkaloid strictosidine in yeast
Brown, S., Clastre, M., Courdavault, V., & O’Connor, S. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423555112 · Cited by 455 · cited 2×
“With the development of synthetic biology, substantial progress has been made in the low-cost production of plant natural products in microbes, including artemisinin (Martin et al., 2003), Taxol (Ajikumar et al., 2010), strictosidine (Brown et al., 2015), and opioids (Galanie et al., 2015).”
BackgroundShibata, S. (2001) · Journal of Korean Medical Science · doi:10.3346/jkms.2001.16.s.s28 · Cited by 449 · cited 1×
“(Shibata, 2001).”
Combinatorial alanine-scanning
Morrison, K. L., & Weiss, G. A. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00206-4 · Cited by 443 · cited 1×
“…S29, and I189 were adjacent (3–5 Å) to PPD, and residues N75, S81, P128, F371 and G372 were 5–10 Å away from PPD. Alanine scanning was a widespread and rapid technique for examining the contribution of an individual amino acid side chain to the functionality of enzymes (Morrison and Weiss, 2001).”
BackgroundVrielink, A., Rüger, W., Driessen, H. P., & Freemont, P. S. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06646.x · Cited by 251 · cited 1×
“UGT51 displayed the same typical GT-B fold as other reported homologs (Vrielink et al., 1994), and it consisted of two β/α/β Rossmann-like domains that faced each other with the active site lying in the resulting cleft.”
BackgroundSubstrate-induced conformational changes in glycosyltransferases
Qasba, P. K., Ramakrishnan, B., & Boeggeman, E. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.005 · Cited by 246 · cited 2×
“conformational changes upon substrate binding (Lairson et al., 2008; Qasba et al., 2005), precisely defining the residues related to acceptor binding and catalytic activity is difficult when the crystal structure of the enzyme-acceptor complex is unknown.”
BackgroundBae, E.-A., Han, M. J., Kim, E.-J., & Kim, D.-H. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980048 · Cited by 240 · cited 1×
“Currently, ginsenoside Rh2 is primarily manufactured by chemical or biological deglycosylation of ginsenosides (Bae et al., 2004; Su et al., 2006; Zhang et al., 2001).”
BackgroundMetabolic engineering of Saccharomyces cerevisiae for production of ginsenosides
Dai, Z., Liu, Y., Zhang, X., Shi, M., Wang, B., Wang, D., Huang, L., & Zhang, X. (2013) · Metabolic Engineering · doi:10.1016/j.ymben.2013.10.004 · Cited by 236 · cited 6×
“1), which was previously engineered for PPD production (Dai et al., 2013).”
BackgroundMethodInfluentialSelf-citationXie, W., Lv, X., Ye, L., Zhou, P., & Yu, H. (2015) · Metabolic Engineering · doi:10.1016/j.ymben.2015.04.009 · Cited by 229 · cited 2×
“The plasmid pUMRI-10 (Xie et al., 2015) was kindly provided by Prof.”
MethodChemical Studies on Crude Drug Precession. I. On the Constituents of Ginseng Radix Rubra (1)
KITAGAWA, I., YOSHIKAWA, M., YOSHIHARA, M., HAYASHI, T., & TANIYAMA, T. (1983) · YAKUGAKU ZASSHI · doi:10.1248/yakushi1947.103.6_612 · Cited by 209
Production of bioactive ginsenosides Rh2 and Rg3 by metabolically engineered yeasts
Wang, P., Wei, Y., Fan, Y., Liu, Q., Wei, W., Yang, C., Zhang, L., Zhao, G., Yue, J., Yan, X., et al. (2015) · Metabolic Engineering · doi:10.1016/j.ymben.2015.03.003 · Cited by 205 · cited 4×
“S6), the best mutant M7-1, which has seven mutations, possesses a similar Km value (280 μM) and a 3.6-fold higher kcat value (1.40 s-1) compared with UGTPg45 (209 μM and 0.38 s-1) (Wang et al., 2015).”
BackgroundInfluentialSelf-citationDietrich, J. A., Yoshikuni, Y., Fisher, K. J., Woolard, F. X., Ockey, D., McPhee, D. J., Renninger, N. S., Chang, M. C. Y., Baker, D., & Keasling, J. D. (2009) · ACS Chemical Biology · doi:10.1021/cb900006h · Cited by 186 · cited 1×
“Besides using plant-derived glycosyltransferase, an alternative way is to use engineered substrate-promiscuous enzymes (Dietrich et al., 2009).”
MethodNakata, H., Kikuchi, Y., Tode, T., Hirata, J., Kita, T., Ishii, K., Kudoh, K., Nagata, I., & Shinomiya, N. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb03278.x · Cited by 182 · cited 1×
“The use of Rh2 in combination with anti-tumor drugs remarkably increased the efficacy of tumor suppression and reduced the side effects caused by chemotherapy (Nakata et al., 1998).”
BackgroundAn evolutionary biochemist's perspective on promiscuity
Copley, S. D. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.12.004 · Cited by 173 · cited 2×
“mations using different substrates (Copley, 2015).”
BackgroundHwang, J.-T., Kim, S.-H., Lee, M.-S., Kim, S. H., Yang, H.-J., Kim, M.-J., Kim, H.-S., Ha, J., Kim, M. S., & Kwon, D. Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.125 · Cited by 172 · cited 1×
“Ginsenoside Rh2 is a trace but important saponin isolated from red ginseng (Kitagawa et al., 1983), and it exhibits diverse pharmacological effects, such as anti-oxidation, hepatoprotection, anti-diabetes and anti-tumor (Hwang et al., 2007; Kim et al., 1999; Liu, 2012).”
BackgroundWarnecke, D. C., Erdmann, R., Fahl, A., Hube, B., Müller, F., Zank, T. K., Zähringer, U., & Heinz, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13048 · Cited by 141
Zhao, F., Bai, P., Liu, T., Li, D., Zhang, X., Lü, W., & Yuan, Y. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.25934 · Cited by 106 · cited 4×
“addition, because of the high efficiency of self-sufficient P450 (Zhao et al., 2016), gene cassette PPDS-75tATR2, which encoded self-sufficient P450 fusion proteins, was integrated into the δ site of strain ZYM7(4)-EΔ-PU(URA3).”
BackgroundInfluentialSelf-citationChemical Insights into Ginseng as a Resource for Natural Antioxidants
Liu, Z. (2012) · Chemical Reviews · doi:10.1021/cr100174k · Cited by 99 · cited 1×
“Ginsenoside Rh2 is a trace but important saponin isolated from red ginseng (Kitagawa et al., 1983), and it exhibits diverse pharmacological effects, such as anti-oxidation, hepatoprotection, anti-diabetes and anti-tumor (Hwang et al., 2007; Kim et al., 1999; Liu, 2012).”
BackgroundLenihan, J. R., Tsuruta, H., Diola, D., Renninger, N. S., & Regentin, R. (2008) · Biotechnology Progress · doi:10.1002/btpr.27 · Cited by 85 · cited 2×
“The media for seed and batch fermentation were modified from previously described media (Lenihan et al., 2008), and 5g/L of lysine was added.”
MethodKim, H.-E., Oh, J. H., Lee, S. K., & Oh, Y. J. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00252-0 · Cited by 58 · cited 1×
“Ginsenoside Rh2 is a trace but important saponin isolated from red ginseng (Kitagawa et al., 1983), and it exhibits diverse pharmacological effects, such as anti-oxidation, hepatoprotection, anti-diabetes and anti-tumor (Hwang et al., 2007; Kim et al., 1999; Liu, 2012).”
BackgroundKamra, P., Gokhale, R. S., & Mohanty, D. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki449 · Cited by 48 · cited 1×
“Therefore, further mutagenesis design was conducted using SEARCHGTr (Kamra et al., 2005) to predict the putative substrate binding residues based on the comprehensive sequence/structure alignment with the reported crystal structures of the glycosyltransferase-acceptor complex.”
MethodA Gene‐Fusion Approach to Enabling Plant Cytochromes P450 for Biocatalysis
Schückel, J., Rylott, E. L., Grogan, G., & Bruce, N. C. (2012) · ChemBioChem · doi:10.1002/cbic.201200572 · Cited by 44 · cited 2×
“The conversion of dammarenediol II to PPD was catalyzed by P450 (PgPPDS) and its reductase, ATR1, in our engineered strains.”
BackgroundWatanabe, T., Ito, T., Goda, H. M., Ishibashi, Y., Miyamoto, T., Ikeda, K., Taguchi, R., Okino, N., & Ito, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.616300 · Cited by 38 · cited 1×
“S4A) (Watanabe et al., 2015a, 2015b).”
Physiological Significance of Glycolipid Catabolism in Cryptococcus neoformans
Watanabe, T., Ishibashi, Y., & Ito, M. (2015) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.1504.1e · Cited by 1 · cited 1×
“S4A) (Watanabe et al., 2015a, 2015b).”
Cited by
Ginsenosides in Panax genus and their biosynthesis
Hou, M., Wang, R., Zhao, S., & Wang, Z. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.12.017 · Cited by 370
Protein Engineering for Improving and Diversifying Natural Product Biosynthesis
Li, C., Zhang, R., Wang, J., Wilson, L. M., & Yan, Y. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.12.008 · Cited by 192
“By further blocking the degradation pathway of Rh2 and increasing the availability of the precursor UDP-glucose, the titer of Rh2 reached 300 mg/L with an over 900-fold increase compared with the starting strain [19].”
Background
Metadata
- Authors
- Zhuang, Y., Yang, G.-Y., Chen, X., Liu, Q., Zhang, X., Deng, Z., & Feng, Y.
- Venue
- Metabolic Engineering
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 42
- Pages
- 25-32
- ISSN
- 1096-7176 (ISSN-L)
- OpenAlex
- W2611356812
- Cited by
- 170
- References
- 29
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.